Also, Yoon et al. (39) and Zhan et al. (33) reported about 17% and 10% of the HER-2 overexpression in the esophageal adenocarcinomas and ESCC tumors, respectively. This evidence concerns the gene ERBB2 and esophageal adenocarcinoma.